nodes	percent_of_prediction	percent_of_DWPC	metapath
Moxifloxacin—TOP2A—Methylergometrine—Bromocriptine—type 2 diabetes mellitus	0.00863	0.724	CbGdCrCtD
Moxifloxacin—TOP2A—Gastric Cancer Network 2—S100A6—type 2 diabetes mellitus	0.00412	0.171	CbGpPWpGaD
Moxifloxacin—TOP2A—Bortezomib—Nateglinide—type 2 diabetes mellitus	0.00329	0.276	CbGdCrCtD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—FAF1—type 2 diabetes mellitus	0.00238	0.0987	CbGpPWpGaD
Moxifloxacin—Sparfloxacin—ABCC2—type 2 diabetes mellitus	0.00234	0.142	CrCbGaD
Moxifloxacin—Lomefloxacin—ABCC2—type 2 diabetes mellitus	0.00193	0.117	CrCbGaD
Moxifloxacin—Enoxacin—CYP1A2—type 2 diabetes mellitus	0.0017	0.103	CrCbGaD
Moxifloxacin—Ofloxacin—ABCC2—type 2 diabetes mellitus	0.00165	0.1	CrCbGaD
Moxifloxacin—Gatifloxacin—ALB—type 2 diabetes mellitus	0.00138	0.084	CrCbGaD
Moxifloxacin—Lomefloxacin—CYP1A2—type 2 diabetes mellitus	0.00129	0.0782	CrCbGaD
Moxifloxacin—Ofloxacin—CYP1A2—type 2 diabetes mellitus	0.0011	0.0668	CrCbGaD
Moxifloxacin—Levofloxacin—CYP1A2—type 2 diabetes mellitus	0.0011	0.0668	CrCbGaD
Moxifloxacin—Ciprofloxacin—CYP1A2—type 2 diabetes mellitus	0.00106	0.0645	CrCbGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—CARTPT—type 2 diabetes mellitus	0.00104	0.043	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—AGRP—type 2 diabetes mellitus	0.000924	0.0383	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—PROX1—type 2 diabetes mellitus	0.000924	0.0383	CbGpPWpGaD
Moxifloxacin—Norfloxacin—CYP1A2—type 2 diabetes mellitus	0.000892	0.0542	CrCbGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—PTGDS—type 2 diabetes mellitus	0.000739	0.0306	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—AANAT—type 2 diabetes mellitus	0.000739	0.0306	CbGpPWpGaD
Moxifloxacin—Levofloxacin—CYP3A4—type 2 diabetes mellitus	0.000728	0.0442	CrCbGaD
Moxifloxacin—Ciprofloxacin—CYP3A4—type 2 diabetes mellitus	0.000703	0.0427	CrCbGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—MTNR1A—type 2 diabetes mellitus	0.000668	0.0277	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—PAX4—type 2 diabetes mellitus	0.000596	0.0247	CbGpPWpGaD
Moxifloxacin—Norfloxacin—CYP3A4—type 2 diabetes mellitus	0.00059	0.0359	CrCbGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PLN—type 2 diabetes mellitus	0.000568	0.0235	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—DNMT1—type 2 diabetes mellitus	0.000534	0.0221	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—STAR—type 2 diabetes mellitus	0.000507	0.021	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—HNF1B—type 2 diabetes mellitus	0.000413	0.0171	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—PSMD6—type 2 diabetes mellitus	0.000376	0.0156	CbGpPWpGaD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—type 2 diabetes mellitus	0.000366	0.0151	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—PRKAA1—type 2 diabetes mellitus	0.000354	0.0147	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—MTNR1B—type 2 diabetes mellitus	0.000351	0.0145	CbGpPWpGaD
Moxifloxacin—TOP2A—Gastric Cancer Network 2—EGFR—type 2 diabetes mellitus	0.000338	0.014	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—HNF4A—type 2 diabetes mellitus	0.000326	0.0135	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—IAPP—type 2 diabetes mellitus	0.000316	0.0131	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—CPT1A—type 2 diabetes mellitus	0.000313	0.013	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—NAMPT—type 2 diabetes mellitus	0.000307	0.0127	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CCND2—type 2 diabetes mellitus	0.000307	0.0127	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—F7—type 2 diabetes mellitus	0.000291	0.0121	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2B—type 2 diabetes mellitus	0.000275	0.0114	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—SREBF1—type 2 diabetes mellitus	0.000274	0.0113	CbGpPWpGaD
Moxifloxacin—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000266	0.00028	CcSEcCtD
Moxifloxacin—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000266	0.00028	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000265	0.00028	CcSEcCtD
Moxifloxacin—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000265	0.00028	CcSEcCtD
Moxifloxacin—Vertigo—Losartan—type 2 diabetes mellitus	0.000265	0.000279	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000265	0.000279	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000265	0.000279	CcSEcCtD
Moxifloxacin—Somnolence—Valsartan—type 2 diabetes mellitus	0.000264	0.000279	CcSEcCtD
Moxifloxacin—Syncope—Losartan—type 2 diabetes mellitus	0.000264	0.000279	CcSEcCtD
Moxifloxacin—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000264	0.000278	CcSEcCtD
Moxifloxacin—Leukopenia—Losartan—type 2 diabetes mellitus	0.000264	0.000278	CcSEcCtD
Moxifloxacin—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000263	0.000278	CcSEcCtD
Moxifloxacin—Skin disorder—Metformin—type 2 diabetes mellitus	0.000263	0.000278	CcSEcCtD
Moxifloxacin—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000262	0.000277	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000262	0.000276	CcSEcCtD
Moxifloxacin—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000262	0.000276	CcSEcCtD
Moxifloxacin—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000262	0.000276	CcSEcCtD
Moxifloxacin—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000261	0.000275	CcSEcCtD
Moxifloxacin—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000261	0.000275	CcSEcCtD
Moxifloxacin—Palpitations—Losartan—type 2 diabetes mellitus	0.00026	0.000275	CcSEcCtD
Moxifloxacin—Nausea—Glimepiride—type 2 diabetes mellitus	0.00026	0.000274	CcSEcCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—GHRL—type 2 diabetes mellitus	0.000259	0.0107	CbGpPWpGaD
Moxifloxacin—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000259	0.000274	CcSEcCtD
Moxifloxacin—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000259	0.000273	CcSEcCtD
Moxifloxacin—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000259	0.000273	CcSEcCtD
Moxifloxacin—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000259	0.000273	CcSEcCtD
Moxifloxacin—Asthenia—Glyburide—type 2 diabetes mellitus	0.000259	0.000273	CcSEcCtD
Moxifloxacin—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000258	0.000273	CcSEcCtD
Moxifloxacin—Anorexia—Metformin—type 2 diabetes mellitus	0.000258	0.000272	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNFRSF1A—type 2 diabetes mellitus	0.000258	0.0107	CbGpPWpGaD
Moxifloxacin—Cough—Losartan—type 2 diabetes mellitus	0.000257	0.000271	CcSEcCtD
Moxifloxacin—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000257	0.000271	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000257	0.000271	CcSEcCtD
Moxifloxacin—Fatigue—Valsartan—type 2 diabetes mellitus	0.000256	0.000271	CcSEcCtD
Moxifloxacin—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000256	0.00027	CcSEcCtD
Moxifloxacin—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000256	0.00027	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000256	0.00027	CcSEcCtD
Moxifloxacin—Oedema—Irbesartan—type 2 diabetes mellitus	0.000256	0.00027	CcSEcCtD
Moxifloxacin—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000255	0.00027	CcSEcCtD
Moxifloxacin—Pruritus—Glyburide—type 2 diabetes mellitus	0.000255	0.000269	CcSEcCtD
Moxifloxacin—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000254	0.000268	CcSEcCtD
Moxifloxacin—Constipation—Valsartan—type 2 diabetes mellitus	0.000254	0.000268	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000254	0.000268	CcSEcCtD
Moxifloxacin—Fatigue—Orlistat—type 2 diabetes mellitus	0.000253	0.000267	CcSEcCtD
Moxifloxacin—Hypotension—Metformin—type 2 diabetes mellitus	0.000253	0.000267	CcSEcCtD
Moxifloxacin—Erythema—Ramipril—type 2 diabetes mellitus	0.000253	0.000267	CcSEcCtD
Moxifloxacin—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000253	0.000267	CcSEcCtD
Moxifloxacin—Shock—Irbesartan—type 2 diabetes mellitus	0.000251	0.000265	CcSEcCtD
Moxifloxacin—Pain—Orlistat—type 2 diabetes mellitus	0.000251	0.000265	CcSEcCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—ADIPOQ—type 2 diabetes mellitus	0.000251	0.0104	CbGpPWpGaD
Moxifloxacin—Myalgia—Losartan—type 2 diabetes mellitus	0.000251	0.000265	CcSEcCtD
Moxifloxacin—Chest pain—Losartan—type 2 diabetes mellitus	0.000251	0.000265	CcSEcCtD
Moxifloxacin—Arthralgia—Losartan—type 2 diabetes mellitus	0.000251	0.000265	CcSEcCtD
Moxifloxacin—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000251	0.000265	CcSEcCtD
Moxifloxacin—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000251	0.000264	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.00025	0.000264	CcSEcCtD
Moxifloxacin—Anxiety—Losartan—type 2 diabetes mellitus	0.00025	0.000264	CcSEcCtD
Moxifloxacin—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000249	0.000263	CcSEcCtD
Moxifloxacin—Rash—Bromocriptine—type 2 diabetes mellitus	0.000249	0.000262	CcSEcCtD
Moxifloxacin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000248	0.000262	CcSEcCtD
Moxifloxacin—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000248	0.000262	CcSEcCtD
Moxifloxacin—Tension—Ramipril—type 2 diabetes mellitus	0.000248	0.000262	CcSEcCtD
Moxifloxacin—Discomfort—Losartan—type 2 diabetes mellitus	0.000248	0.000262	CcSEcCtD
Moxifloxacin—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000247	0.000261	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000247	0.000261	CcSEcCtD
Moxifloxacin—Headache—Bromocriptine—type 2 diabetes mellitus	0.000247	0.000261	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000247	0.00026	CcSEcCtD
Moxifloxacin—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000247	0.00026	CcSEcCtD
Moxifloxacin—Nervousness—Ramipril—type 2 diabetes mellitus	0.000245	0.000259	CcSEcCtD
Moxifloxacin—Dry mouth—Losartan—type 2 diabetes mellitus	0.000245	0.000259	CcSEcCtD
Moxifloxacin—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000244	0.000257	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000243	0.000257	CcSEcCtD
Moxifloxacin—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000243	0.000257	CcSEcCtD
Moxifloxacin—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000243	0.000256	CcSEcCtD
Moxifloxacin—Confusional state—Losartan—type 2 diabetes mellitus	0.000242	0.000256	CcSEcCtD
Moxifloxacin—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000242	0.000256	CcSEcCtD
Moxifloxacin—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000241	0.000255	CcSEcCtD
Moxifloxacin—Somnolence—Metformin—type 2 diabetes mellitus	0.000241	0.000254	CcSEcCtD
Moxifloxacin—Oedema—Losartan—type 2 diabetes mellitus	0.00024	0.000254	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.00024	0.000254	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.00024	0.000254	CcSEcCtD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—PPP2CA—type 2 diabetes mellitus	0.00024	0.00994	CbGpPWpGaD
Moxifloxacin—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000239	0.000252	CcSEcCtD
Moxifloxacin—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000238	0.000252	CcSEcCtD
Moxifloxacin—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000238	0.000252	CcSEcCtD
Moxifloxacin—Tremor—Ramipril—type 2 diabetes mellitus	0.000237	0.00025	CcSEcCtD
Moxifloxacin—Shock—Losartan—type 2 diabetes mellitus	0.000237	0.00025	CcSEcCtD
Moxifloxacin—Urticaria—Valsartan—type 2 diabetes mellitus	0.000236	0.000249	CcSEcCtD
Moxifloxacin—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000236	0.000249	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000235	0.000249	CcSEcCtD
Moxifloxacin—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000235	0.000248	CcSEcCtD
Moxifloxacin—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000235	0.000248	CcSEcCtD
Moxifloxacin—Tachycardia—Losartan—type 2 diabetes mellitus	0.000235	0.000248	CcSEcCtD
Moxifloxacin—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000234	0.000247	CcSEcCtD
Moxifloxacin—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000234	0.000247	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000234	0.000247	CcSEcCtD
Moxifloxacin—Fatigue—Metformin—type 2 diabetes mellitus	0.000233	0.000246	CcSEcCtD
Moxifloxacin—Urticaria—Orlistat—type 2 diabetes mellitus	0.000233	0.000246	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000233	0.000246	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000232	0.000245	CcSEcCtD
Moxifloxacin—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000232	0.000245	CcSEcCtD
Moxifloxacin—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000232	0.000245	CcSEcCtD
Moxifloxacin—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000232	0.000245	CcSEcCtD
Moxifloxacin—Agitation—Ramipril—type 2 diabetes mellitus	0.000232	0.000245	CcSEcCtD
Moxifloxacin—Constipation—Metformin—type 2 diabetes mellitus	0.000232	0.000244	CcSEcCtD
Moxifloxacin—Angioedema—Ramipril—type 2 diabetes mellitus	0.000231	0.000244	CcSEcCtD
Moxifloxacin—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000229	0.000242	CcSEcCtD
Moxifloxacin—Anorexia—Losartan—type 2 diabetes mellitus	0.000229	0.000242	CcSEcCtD
Moxifloxacin—Vomiting—Glyburide—type 2 diabetes mellitus	0.000229	0.000242	CcSEcCtD
Moxifloxacin—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000229	0.000242	CcSEcCtD
Moxifloxacin—Malaise—Ramipril—type 2 diabetes mellitus	0.000228	0.00024	CcSEcCtD
Moxifloxacin—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000228	0.00024	CcSEcCtD
Moxifloxacin—Rash—Glyburide—type 2 diabetes mellitus	0.000227	0.00024	CcSEcCtD
Moxifloxacin—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000227	0.00024	CcSEcCtD
Moxifloxacin—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000227	0.00024	CcSEcCtD
Moxifloxacin—Vertigo—Ramipril—type 2 diabetes mellitus	0.000227	0.00024	CcSEcCtD
Moxifloxacin—Syncope—Ramipril—type 2 diabetes mellitus	0.000227	0.000239	CcSEcCtD
Moxifloxacin—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000226	0.000239	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AR—type 2 diabetes mellitus	0.000226	0.00936	CbGpPWpGaD
Moxifloxacin—Headache—Glyburide—type 2 diabetes mellitus	0.000226	0.000238	CcSEcCtD
Moxifloxacin—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000225	0.000237	CcSEcCtD
Moxifloxacin—Hypotension—Losartan—type 2 diabetes mellitus	0.000225	0.000237	CcSEcCtD
Moxifloxacin—Palpitations—Ramipril—type 2 diabetes mellitus	0.000223	0.000236	CcSEcCtD
Moxifloxacin—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000223	0.000235	CcSEcCtD
Moxifloxacin—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000222	0.000234	CcSEcCtD
Moxifloxacin—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000222	0.000234	CcSEcCtD
Moxifloxacin—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000221	0.000234	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000221	0.000234	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000221	0.000233	CcSEcCtD
Moxifloxacin—Cough—Ramipril—type 2 diabetes mellitus	0.00022	0.000233	CcSEcCtD
Moxifloxacin—Fatigue—Irbesartan—type 2 diabetes mellitus	0.00022	0.000233	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000219	0.000231	CcSEcCtD
Moxifloxacin—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000219	0.000231	CcSEcCtD
Moxifloxacin—Convulsion—Ramipril—type 2 diabetes mellitus	0.000219	0.000231	CcSEcCtD
Moxifloxacin—Pain—Irbesartan—type 2 diabetes mellitus	0.000219	0.000231	CcSEcCtD
Moxifloxacin—Constipation—Irbesartan—type 2 diabetes mellitus	0.000219	0.000231	CcSEcCtD
Moxifloxacin—Insomnia—Losartan—type 2 diabetes mellitus	0.000218	0.00023	CcSEcCtD
Moxifloxacin—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000216	0.000228	CcSEcCtD
Moxifloxacin—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000216	0.000228	CcSEcCtD
Moxifloxacin—Urticaria—Metformin—type 2 diabetes mellitus	0.000215	0.000227	CcSEcCtD
Moxifloxacin—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000215	0.000227	CcSEcCtD
Moxifloxacin—Chest pain—Ramipril—type 2 diabetes mellitus	0.000215	0.000227	CcSEcCtD
Moxifloxacin—Myalgia—Ramipril—type 2 diabetes mellitus	0.000215	0.000227	CcSEcCtD
Moxifloxacin—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000214	0.000226	CcSEcCtD
Moxifloxacin—Anxiety—Ramipril—type 2 diabetes mellitus	0.000214	0.000226	CcSEcCtD
Moxifloxacin—Nausea—Glyburide—type 2 diabetes mellitus	0.000214	0.000226	CcSEcCtD
Moxifloxacin—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000214	0.000226	CcSEcCtD
Moxifloxacin—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000214	0.000226	CcSEcCtD
Moxifloxacin—Somnolence—Losartan—type 2 diabetes mellitus	0.000214	0.000226	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000214	0.000225	CcSEcCtD
Moxifloxacin—Asthenia—Valsartan—type 2 diabetes mellitus	0.000213	0.000225	CcSEcCtD
Moxifloxacin—Discomfort—Ramipril—type 2 diabetes mellitus	0.000213	0.000224	CcSEcCtD
Moxifloxacin—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000212	0.000223	CcSEcCtD
Moxifloxacin—Asthenia—Orlistat—type 2 diabetes mellitus	0.000211	0.000222	CcSEcCtD
Moxifloxacin—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000211	0.000222	CcSEcCtD
Moxifloxacin—Pruritus—Valsartan—type 2 diabetes mellitus	0.00021	0.000222	CcSEcCtD
Moxifloxacin—Dry mouth—Ramipril—type 2 diabetes mellitus	0.00021	0.000222	CcSEcCtD
Moxifloxacin—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000209	0.000221	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000209	0.000221	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN2B—type 2 diabetes mellitus	0.000208	0.00863	CbGpPWpGaD
Moxifloxacin—Confusional state—Ramipril—type 2 diabetes mellitus	0.000208	0.000219	CcSEcCtD
Moxifloxacin—Pruritus—Orlistat—type 2 diabetes mellitus	0.000208	0.000219	CcSEcCtD
Moxifloxacin—Fatigue—Losartan—type 2 diabetes mellitus	0.000207	0.000219	CcSEcCtD
Moxifloxacin—Oedema—Ramipril—type 2 diabetes mellitus	0.000206	0.000218	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000206	0.000218	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SIRT1—type 2 diabetes mellitus	0.000206	0.00853	CbGpPWpGaD
Moxifloxacin—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000206	0.000217	CcSEcCtD
Moxifloxacin—Pain—Losartan—type 2 diabetes mellitus	0.000206	0.000217	CcSEcCtD
Moxifloxacin—Constipation—Losartan—type 2 diabetes mellitus	0.000206	0.000217	CcSEcCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—PPARGC1A—type 2 diabetes mellitus	0.000204	0.00847	CbGpPWpGaD
Moxifloxacin—Rash—Gliclazide—type 2 diabetes mellitus	0.000204	0.000215	CcSEcCtD
Moxifloxacin—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000204	0.000215	CcSEcCtD
Moxifloxacin—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000203	0.000215	CcSEcCtD
Moxifloxacin—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000203	0.000214	CcSEcCtD
Moxifloxacin—Shock—Ramipril—type 2 diabetes mellitus	0.000203	0.000214	CcSEcCtD
Moxifloxacin—Headache—Gliclazide—type 2 diabetes mellitus	0.000203	0.000214	CcSEcCtD
Moxifloxacin—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000202	0.000213	CcSEcCtD
Moxifloxacin—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000202	0.000213	CcSEcCtD
Moxifloxacin—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000202	0.000213	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000202	0.000213	CcSEcCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—AVP—type 2 diabetes mellitus	0.000202	0.00835	CbGpPWpGaD
Moxifloxacin—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000201	0.000212	CcSEcCtD
Moxifloxacin—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000201	0.000212	CcSEcCtD
Moxifloxacin—Skin disorder—Ramipril—type 2 diabetes mellitus	0.0002	0.000211	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000199	0.00021	CcSEcCtD
Moxifloxacin—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000198	0.000209	CcSEcCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—SIRT1—type 2 diabetes mellitus	0.000198	0.00819	CbGpPWpGaD
Moxifloxacin—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000197	0.000208	CcSEcCtD
Moxifloxacin—Dizziness—Valsartan—type 2 diabetes mellitus	0.000197	0.000208	CcSEcCtD
Moxifloxacin—Anorexia—Ramipril—type 2 diabetes mellitus	0.000197	0.000207	CcSEcCtD
Moxifloxacin—Dizziness—Orlistat—type 2 diabetes mellitus	0.000194	0.000205	CcSEcCtD
Moxifloxacin—Asthenia—Metformin—type 2 diabetes mellitus	0.000194	0.000205	CcSEcCtD
Moxifloxacin—Hypotension—Ramipril—type 2 diabetes mellitus	0.000193	0.000203	CcSEcCtD
Moxifloxacin—Nausea—Gliclazide—type 2 diabetes mellitus	0.000192	0.000203	CcSEcCtD
Moxifloxacin—Pruritus—Metformin—type 2 diabetes mellitus	0.000192	0.000202	CcSEcCtD
Moxifloxacin—Urticaria—Losartan—type 2 diabetes mellitus	0.000191	0.000202	CcSEcCtD
Moxifloxacin—Abdominal pain—Losartan—type 2 diabetes mellitus	0.00019	0.000201	CcSEcCtD
Moxifloxacin—Body temperature increased—Losartan—type 2 diabetes mellitus	0.00019	0.000201	CcSEcCtD
Moxifloxacin—Vomiting—Valsartan—type 2 diabetes mellitus	0.000189	0.0002	CcSEcCtD
Moxifloxacin—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000188	0.000199	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000188	0.000198	CcSEcCtD
Moxifloxacin—Rash—Valsartan—type 2 diabetes mellitus	0.000187	0.000198	CcSEcCtD
Moxifloxacin—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000187	0.000198	CcSEcCtD
Moxifloxacin—Vomiting—Orlistat—type 2 diabetes mellitus	0.000187	0.000197	CcSEcCtD
Moxifloxacin—Insomnia—Ramipril—type 2 diabetes mellitus	0.000186	0.000197	CcSEcCtD
Moxifloxacin—Headache—Valsartan—type 2 diabetes mellitus	0.000186	0.000197	CcSEcCtD
Moxifloxacin—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000185	0.000196	CcSEcCtD
Moxifloxacin—Rash—Orlistat—type 2 diabetes mellitus	0.000185	0.000196	CcSEcCtD
Moxifloxacin—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000185	0.000195	CcSEcCtD
Moxifloxacin—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000185	0.000195	CcSEcCtD
Moxifloxacin—Headache—Orlistat—type 2 diabetes mellitus	0.000184	0.000194	CcSEcCtD
Moxifloxacin—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000184	0.000194	CcSEcCtD
Moxifloxacin—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000183	0.000193	CcSEcCtD
Moxifloxacin—Somnolence—Ramipril—type 2 diabetes mellitus	0.000183	0.000193	CcSEcCtD
Moxifloxacin—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000182	0.000192	CcSEcCtD
Moxifloxacin—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000181	0.000191	CcSEcCtD
Moxifloxacin—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000179	0.000189	CcSEcCtD
Moxifloxacin—Dizziness—Metformin—type 2 diabetes mellitus	0.000179	0.000189	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000178	0.000188	CcSEcCtD
Moxifloxacin—Fatigue—Ramipril—type 2 diabetes mellitus	0.000178	0.000188	CcSEcCtD
Moxifloxacin—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000177	0.000187	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FAS—type 2 diabetes mellitus	0.000177	0.00733	CbGpPWpGaD
Moxifloxacin—Nausea—Valsartan—type 2 diabetes mellitus	0.000177	0.000186	CcSEcCtD
Moxifloxacin—Constipation—Ramipril—type 2 diabetes mellitus	0.000176	0.000186	CcSEcCtD
Moxifloxacin—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000175	0.000185	CcSEcCtD
Moxifloxacin—Nausea—Orlistat—type 2 diabetes mellitus	0.000175	0.000184	CcSEcCtD
Moxifloxacin—Asthenia—Losartan—type 2 diabetes mellitus	0.000173	0.000182	CcSEcCtD
Moxifloxacin—Vomiting—Metformin—type 2 diabetes mellitus	0.000172	0.000182	CcSEcCtD
Moxifloxacin—Rash—Metformin—type 2 diabetes mellitus	0.000171	0.00018	CcSEcCtD
Moxifloxacin—Dermatitis—Metformin—type 2 diabetes mellitus	0.000171	0.00018	CcSEcCtD
Moxifloxacin—Pruritus—Losartan—type 2 diabetes mellitus	0.00017	0.00018	CcSEcCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—FAS—type 2 diabetes mellitus	0.00017	0.00704	CbGpPWpGaD
Moxifloxacin—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.00017	0.000179	CcSEcCtD
Moxifloxacin—Headache—Metformin—type 2 diabetes mellitus	0.00017	0.000179	CcSEcCtD
Moxifloxacin—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000169	0.000178	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000169	0.000178	CcSEcCtD
Moxifloxacin—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000165	0.000174	CcSEcCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—PPARA—type 2 diabetes mellitus	0.000164	0.00681	CbGpPWpGaD
Moxifloxacin—Urticaria—Ramipril—type 2 diabetes mellitus	0.000164	0.000173	CcSEcCtD
Moxifloxacin—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000163	0.000172	CcSEcCtD
Moxifloxacin—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000163	0.000172	CcSEcCtD
Moxifloxacin—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000162	0.000171	CcSEcCtD
Moxifloxacin—Rash—Irbesartan—type 2 diabetes mellitus	0.000161	0.00017	CcSEcCtD
Moxifloxacin—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000161	0.00017	CcSEcCtD
Moxifloxacin—Nausea—Metformin—type 2 diabetes mellitus	0.000161	0.00017	CcSEcCtD
Moxifloxacin—Headache—Irbesartan—type 2 diabetes mellitus	0.00016	0.000169	CcSEcCtD
Moxifloxacin—Dizziness—Losartan—type 2 diabetes mellitus	0.000159	0.000168	CcSEcCtD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—type 2 diabetes mellitus	0.000157	0.00651	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—LEP—type 2 diabetes mellitus	0.000156	0.00646	CbGpPWpGaD
Moxifloxacin—Vomiting—Losartan—type 2 diabetes mellitus	0.000153	0.000161	CcSEcCtD
Moxifloxacin—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000152	0.00016	CcSEcCtD
Moxifloxacin—Nausea—Irbesartan—type 2 diabetes mellitus	0.000152	0.00016	CcSEcCtD
Moxifloxacin—Rash—Losartan—type 2 diabetes mellitus	0.000152	0.00016	CcSEcCtD
Moxifloxacin—Dermatitis—Losartan—type 2 diabetes mellitus	0.000151	0.00016	CcSEcCtD
Moxifloxacin—Headache—Losartan—type 2 diabetes mellitus	0.000151	0.000159	CcSEcCtD
Moxifloxacin—Asthenia—Ramipril—type 2 diabetes mellitus	0.000148	0.000156	CcSEcCtD
Moxifloxacin—Pruritus—Ramipril—type 2 diabetes mellitus	0.000146	0.000154	CcSEcCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—NOS2—type 2 diabetes mellitus	0.000145	0.00602	CbGpPWpGaD
Moxifloxacin—Nausea—Losartan—type 2 diabetes mellitus	0.000143	0.000151	CcSEcCtD
Moxifloxacin—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000141	0.000149	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—PSMD6—type 2 diabetes mellitus	0.000138	0.00571	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—type 2 diabetes mellitus	0.000137	0.00566	CbGpPWpGaD
Moxifloxacin—Dizziness—Ramipril—type 2 diabetes mellitus	0.000136	0.000144	CcSEcCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—PPARG—type 2 diabetes mellitus	0.000136	0.00563	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—IGF1—type 2 diabetes mellitus	0.000134	0.00556	CbGpPWpGaD
Moxifloxacin—Vomiting—Ramipril—type 2 diabetes mellitus	0.000131	0.000138	CcSEcCtD
Moxifloxacin—Rash—Ramipril—type 2 diabetes mellitus	0.00013	0.000137	CcSEcCtD
Moxifloxacin—Dermatitis—Ramipril—type 2 diabetes mellitus	0.00013	0.000137	CcSEcCtD
Moxifloxacin—Headache—Ramipril—type 2 diabetes mellitus	0.000129	0.000136	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle—PSMD6—type 2 diabetes mellitus	0.000123	0.00511	CbGpPWpGaD
Moxifloxacin—Nausea—Ramipril—type 2 diabetes mellitus	0.000122	0.000129	CcSEcCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—SERPINE1—type 2 diabetes mellitus	0.000122	0.00507	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	0.000117	0.00486	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CCND2—type 2 diabetes mellitus	0.000112	0.00466	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	0.000111	0.00461	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	0.000103	0.00428	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2B—type 2 diabetes mellitus	0.000101	0.00418	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CCND2—type 2 diabetes mellitus	0.000101	0.00416	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	9.66e-05	0.004	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CDKN2B—type 2 diabetes mellitus	9.01e-05	0.00373	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	9e-05	0.00373	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—PPP2CA—type 2 diabetes mellitus	8.8e-05	0.00365	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	8.77e-05	0.00363	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	8.05e-05	0.00333	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	7.89e-05	0.00327	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—PPP2CA—type 2 diabetes mellitus	7.87e-05	0.00326	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	7.52e-05	0.00311	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—PRKCB—type 2 diabetes mellitus	7.42e-05	0.00307	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—PRKCB—type 2 diabetes mellitus	6.63e-05	0.00275	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—IL6—type 2 diabetes mellitus	5.82e-05	0.00241	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—type 2 diabetes mellitus	5.76e-05	0.00239	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	5.6e-05	0.00232	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CDKN2A—type 2 diabetes mellitus	5.15e-05	0.00214	CbGpPWpGaD
